Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis--tolerance of therapy. 1994

R S Axtens, and E F Morand, and G O Littlejohn

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

R S Axtens, and E F Morand, and G O Littlejohn
July 1994, British journal of rheumatology,
R S Axtens, and E F Morand, and G O Littlejohn
February 1998, Zeitschrift fur Rheumatologie,
R S Axtens, and E F Morand, and G O Littlejohn
August 1990, British journal of rheumatology,
R S Axtens, and E F Morand, and G O Littlejohn
April 2000, Bangladesh Medical Research Council bulletin,
R S Axtens, and E F Morand, and G O Littlejohn
January 1993, Zeitschrift fur Rheumatologie,
R S Axtens, and E F Morand, and G O Littlejohn
February 1998, Zeitschrift fur Rheumatologie,
R S Axtens, and E F Morand, and G O Littlejohn
June 1988, Clinical rheumatology,
R S Axtens, and E F Morand, and G O Littlejohn
August 1996, British journal of clinical pharmacology,
R S Axtens, and E F Morand, and G O Littlejohn
November 1995, British journal of rheumatology,
Copied contents to your clipboard!